Always remember ruberex share is only 43 cents and climb up till rm3.30..Do you think the increase in earning justifu thr shate price? If yes, go ahesd and Buy...
India's first indigenous Covid-19 antibody (BBV152 COVID immunization) might be launched by August 15. The Indian Council of Medical Research (ICMR) has announced that it is planning to fast track the human clinical trials of coronavirus vaccine which is being developed in partnership with Bharat Biotech International Limited (BBIL). Also read: Bharat Biotech announces DGCI's approval for its "COVAXIN" COVID-19 vaccine for Phase I & II human clinical trials ICMR Director General Balram Bhargava, in a letter to the heads of the selected institutions, informed them that it has partnered with Hyderabad-based Bharat Biotech International Limited (BBIL) to fast-track clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine). "The vaccine is being derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine," he wrote. The ICMR has selected 12 institutes, including one from Odisha, for the clinical trial of the country's first indigenous COVID-19 vaccine. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government. The institutes selected for the clinical trial are Bhubaneswar's IMS and SUM Hospital, and other institutes are located in Visakhapatnam, Rohtak, New Delhi, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Kattankulathur (Tamil Nadu), Hyderabad, Arya Nagar, Kanpur (Uttar Pradesh) and Goa.
Bad news for Chinese vaccines! The Chinese government and Kang Xinuo Biotechnology Co., Ltd. developed the Coronavirus vaccine "Ad5-nCoV" previously said that it passed the first and second phases of clinical trials and began to inoculate the PLA personnel, but there are foreign medical authoritative journals (Lancet) pointed out: there are almost Half of the vaccinated staff had a fever, 44% of the vaccinated staff were fatigued, 39% of the staff experienced headaches and other side effects, and even 9% of them experienced "impeded activity"‼ ️
Glove stocks will continue to rise. I buy Careplus gloves stock and wait for the price to double!
gud job to those who bought the share in June..just relax & let the price gain momentum steadily through this 1st & 2nd week..there might be a little pullback ahead but don't worry, that's ruberex..that's why i opt for ruberex rather than comfort or careplus..parabolic price hike will only kill u faster
Tomolo Agm meeting.... No problem limit up.... Pump in pump in... The rest top4 is too high unless qr out..... Tomolo show time is Rubberex, comfort, adventa, carerpls.......
think too much, up also big 4 up lah, 2nd 3rd 4th line for healthcare all wont up too much adi 1. So many retailer bossess and black money go back to business already, where got so many hot money goreng 2nd 3rd 4th line hehe
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
skyhin
523 posts
Posted by skyhin > 2020-07-03 21:38 | Report Abuse
Coming tsunami by monday...... Before Tuesday... Will hit TP 4.00 by next Tuesday.... Monday remember buy asap if got bullet...